Leukemia Flashcards
(43 cards)
Most common childhood cancer (peak age ~4 years)
Acute Lymphoblastic Leukemia
Definition of ALL
Malignancy of lymphoblasts (immature B or T cells)
Most common childhood cancer (peak age ~4 years)
May cause marrow suppression (anemia, thrombocytopenia, neutropenia)
Clinical Features of ALL
Bone pain (marrow expansion)
Fever, fatigue
Hepatosplenomegaly, lymphadenopathy
CNS involvement: Headache, vomiting, meningeal spread
In diagnosis of ALL
CBC , bone marrow biopsy, flow cytometry will show? Respectively
Anemia, thrombocytopenia, lymphoblasts
Hypercellular marrow with >20% lymphoblasts
o Pre-B cell (most common): CD10 (CALLA), CD19, CD22
o Pre-T cell: CD2, CD3, CD5, CD7
o TdT+ (marker of immature lymphoid cells)
TdT+
ALL (marker of immature lymphoid cells)
Genetic association with ALL
………… Good prognosis(common in children)
………… Poor prognosis(more common in adults)
………… (10–20× increased risk) for ALL
t(12;21) TEL-AML1
t(9;22) Philadelphia chromosome (BCR-ABL)
Down Syndrome
Good prognosis (>85% cure rate in children)
ALL
Treatment of ALL
Induction therapy (Vincristine, steroids, Asparaginase)
CNS prophylaxis (intrathecal chemotherapy)
Most common acute leukemia in adults (median age 65 years)
Acute Myeloid Leukemia (AML)
Splenomegaly uncommon
Acute Myeloid Leukemia
Clinical Features of AML
Symptoms from marrow failure:
o Anemia → Fatigue, pallor
o Thrombocytopenia → Bleeding (gums, petechiae)
o Neutropenia → Infections
Splenomegaly uncommon (contrast with ALL)
LDH often elevated (high cell turnover)
How to diagnose AML
CBC: Anemia, thrombocytopenia, variable WBC
Bone marrow biopsy: >20% myeloblasts
Peripheral smear: Auer rods (pathognomonic)
Myeloperoxidase (MPO) positive (marker of myeloid lineage)
Peripheral smear: Auer rods (pathognomonic)
AML
Acute Promyelocytic Leukemia (APML)?
Subtype from AML
DIC common at presentation
Acute Promyelocytic Leukemia (APML)
Translocation: t(15;17) → PML-RARA fusion gene
Acute Promyelocytic Leukemia (APML)
How to treat Acute Promyelocytic Leukemia (APML)
All-Trans Retinoic Acid (ATRA) + Arsenic Trioxide
How to treat AML
Induction therapy: Cytarabine + Daunorubicin
Bone marrow transplant for high-risk cases
Most common leukemia in older adults (>60 years)
Chronic Lymphocytic Leukemia (CLL)
Clinical Features of CLL
Often asymptomatic (found on routine CBC)
Lymphocytosis (>5000/μL)
Lymphadenopathy, hepatosplenomegaly
Autoimmune hemolytic anemia (AIHA)
Recurrent infections (hypogammaglobulinemia)
Autoimmune hemolytic anemia (AIHA) may seen in
CLL
Smudge cells
CLL
Recurrent infections (hypogammaglobulinemia)
CLL
CD19+, CD20+, CD5+ (abnormal for B-cells)
CLL